13 Mar 2026
The WFN March 2026 issue of the OPEN ACCESS journal eNeurologicalSci Vol. 42 is now available online.
13 Mar 2026
12 Mar 2026
Systematic review and meta-analysis aimed to determine the long-term prevalence in COVID-19 survivors of fourteen specific NMDs and related symptoms.
12 Mar 2026
Vol. 483, April 2026 now available
11 Mar 2026
A new review evaluates why monoclonal antibodies (mAbs) targeting α-synuclein have so far failed to demonstrate clinical benefit in Parkinson’s disease (PD), despite strong preclinical promise. Analysing data from five randomised controlled trials, the authors assess safety, pharmacokinetics, central nervous system exposure, and target engagement.
3 Mar 2026
I'd like to warmly welcome all neurologists — and anyone interested in neurology and brain health worldwide — to the first World Neurology issue of 2026. As this is also the first issue under my tenure as World Federation of Neurology (WFN) president, I'd like to introduce you, our readers, to the WFN. I would also like to briefly introduce myself and our goals for my presidential tenure.
2 Mar 2026
Vol. 482, March 2026 now available
17 Feb 2026
A new study highlights the often-overlooked burden of cerebral microvascular involvement in primary antiphospholipid syndrome (PAPS), even in patients without overt neurological events. Using Tc-99m ECD SPECT imaging, the researchers identified consistent cortical perfusion abnormalities that were not detected by conventional MRI, suggesting subclinical brain involvement
9 Feb 2026
27 Jan 2026